Literature DB >> 6631780

Comparison of Naegleria fowleri and Naegleria gruberi cultivated in the same nutrient medium.

M Cline, F Marciano-Cabral, S G Bradley.   

Abstract

The human pathogenic amoeboflagellate Naegleria fowleri and the nonpathogenic species N. gruberi can be cultivated axenically but usually in different media. Naegleria fowleri 6088 has been adapted to grow in Balamuth H-4 medium, usually used to propagate N. gruberi nB81, and nB81 has been adapted to grow in supplemented Nelson's medium, usually used to propagate N. fowleri. N. gruberi nB81, grown in either medium, enflagellated 135 to 150 min after subculture to non-nutrient amoeba saline, whereas 6088 required 225 min. Naegleria gruberi nB81 grown in either medium was agglutinated by 100 micrograms concanavalin A/ml, whereas N. fowleri 6088 was not. Naegleria fowleri and N. gruberi grown in Nelson's medium became rounded to a greater extent upon chilling at 5 degrees C and remained rounded longer than Naegleria grown in Balamuth medium. The specificity of the surface antigens was an inherent characteristic of each species and not dependent upon the propagating medium, but Naegleria grown in Nelson's medium was agglutinated more reproducibly and more effectively by antiserum. N. gruberi was somewhat more resistant to acriflavine, actinomycin D, cycloheximide, or tetracycline than N. fowleri, regardless of the culture medium. Naegleria fowleri 6088 grown in Nelson's medium, however, was more resistant to actinomycin D, daunomycin, mithramycin, sulfamethoxazole, or tyrocidine than 6088 grown in Balamuth medium. There are limitations on the validity of comparisons of N. fowleri and N. gruberi based upon cultures grown in different media.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6631780     DOI: 10.1111/j.1550-7408.1983.tb02936.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  13 in total

1.  Cytopathology of pathogenic and nonpathogenic Naegleria species for cultured rat neuroblastoma cells.

Authors:  F M Marciano-Cabral; D E Fulford
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

Review 2.  Biology of Naegleria spp.

Authors:  F Marciano-Cabral
Journal:  Microbiol Rev       Date:  1988-03

3.  Identification of a Naegleria fowleri membrane protein reactive with anti-human CD59 antibody.

Authors:  Angela E Fritzinger; Denise M Toney; Rebecca C MacLean; Francine Marciano-Cabral
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

4.  Resistance of highly pathogenic Naegleria fowleri amoebae to complement-mediated lysis.

Authors:  L Y Whiteman; F Marciano-Cabral
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

5.  Pathogenic Naegleria fowleri and non-pathogenic Naegleria lovaniensis exhibit differential adhesion to, and invasion of, extracellular matrix proteins.

Authors:  Melissa Jamerson; Bruno da Rocha-Azevedo; Guy A Cabral; Francine Marciano-Cabral
Journal:  Microbiology       Date:  2012-01-05       Impact factor: 2.777

6.  Susceptibility of pathogenic and nonpathogenic Naegleria spp. to complement-mediated lysis.

Authors:  L Y Whiteman; F Marciano-Cabral
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

7.  Host resistance of mice to Naegleria fowleri infections.

Authors:  M F Reilly; K L White; S G Bradley
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

Review 8.  Cultivation of pathogenic and opportunistic free-living amebas.

Authors:  Frederick L Schuster
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  Identification of Naegleria fowleri in warm ground water aquifers.

Authors:  Ian Laseke; Jill Korte; Regina Lamendella; Edna S Kaneshiro; Francine Marciano-Cabral; Daniel B Oerther
Journal:  J Environ Qual       Date:  2009-12-30       Impact factor: 2.751

10.  Alterations in protein expression and complement resistance of pathogenic Naegleria amoebae.

Authors:  D M Toney; F Marciano-Cabral
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.